IRB & Research Compliance
The IRB office is currently not accepting in-person applications.
All questions should be sent to firstname.lastname@example.org.
COVID -19 Update
Kean University has developed a comprehensive Climb Higher Restart Plan. The top priority of Kean IRB is to ensure the safety of the participants as well as the researchers.
All guidelines and requirements that apply to restarting on-campus activities also apply to human subject research. All PIs conducting face-to-face research should review Kean’s COVID policies Researchers are encouraged to take precautions as they resume human subject research. PIs conducting research at another institution should also review the host site’s COVID policies and abide by these while at the host site.
All PIs conducting face-to-face research should have a contingency plan prepared in case there is a need to shift their project to a remote platform. PIs submitting new applications for face-to-face research with the option of shifting to a remote platform as part of their contingency plan should describe how they have prepared options for electronic informed consent and debriefing forms, set up consent for recording within Zoom or any other platforms they may use, planned for electronic storage of data, set up voicemail so they can check their office phone messages remotely or provided alternative means of contact in case participants have questions and adjusted the proposed research so that it can be safely conducted using a virtual platform.
For research at external sites, researchers must comply with the rules and regulations applicable to the host sites. Researchers must obtain written permission from an authorized person at the external research site certifying that approval has been granted to resume research activities at the off-campus location. Researchers must also obtain a list of the COVID-19 related precautions and safety measures that must be taken at the host site.
Kean IRB will continue to monitor OHRP guidelines and the state guidelines and update the website accordingly.
Kean University supports research as an integral element of its mission to advance and disseminate knowledge. The University's practices and policies in support of research firmly uphold the highest standards of ethics and integrity and comply with all federal and state regulations and guidelines. To help fulfill this mission, Kean University has established an Institutional Review Board, an appointed group of researchers from across disciplines, who review all human subjects research applications according to federal and state regulations and university policies. All faculty, students, and employees who conduct research involving human subjects must comply with University Policy and Procedures for the Protection of Human Subjects in Research.
Institutional Review Board
The Institutional Review Board (IRB) is charged with the review of proposed research protocols to ensure that the rights of human subjects are protected and that the risk of harm to subjects is minimized. The framework for the protection of human subjects is set in Federal regulation.
IRB members review all assigned research protocols to ensure that:
- Risks to subjects are minimized
- Risks to subjects are reasonable in relation to anticipated benefits
- Selection of subjects is equitable
- Informed consent is properly obtained from all prospective subjects and documented
- Subject’s privacy and confidentiality are protected
- Appropriate additional safeguards are incorporated for any vulnerable subjects
IRB Application Deadlines - AY2022-2023
|Wednesday, September 21, 2022|
|Wednesday, October 12, 2022|
|Wednesday, November 2, 2022|
|Wednesday, November 23, 2022|
On January 19, 2017, the U.S. Department of Health and Human Services (HHS) and fifteen other federal agencies issued changes to the regulations governing human subject research. These changes will go into effect on January 21, 2019. The regulatory requirements apply differently depending on whether the study was initiated before January 21, 2019, or on or after January 21, 2019. For more information, click here.